Preeclampsia is associated with structural/functional alterations in placental and maternal vasculature. KV7 (voltage-dependant potassium channels encoded by KCNQ1-5 genes) have been detected in several types of blood vessels where they promote vascular relaxation. KV7 channel function can be modulated by KCNE1-5 encoded accessory proteins. The aim of this study was to determine whether KCNQ and KCNE genes are differentially expressed in placentae from women with preeclampsia compared to normotensive controls and to examine any differences in those who delivered preterm (<37 weeks') or term. Placental biopsies (from midway between the cord and periphery) were obtained, with consent, from White European control (n=24, term) and preeclamptic (n=22; of whom 8 delivered before 37 weeks') women. KCNQ/KCNE and GAPDH to the syncytiotrophoblast. KCNQ4 and KCNE1 isoforms were suppressed in placenta from term preeclamptic women versus controls (p≤0.05). KCNQ1 mRNA expression was increased and KCNQ5 decreased in the preterm preeclamptic group versus controls (p<0.05). In summary, KV7 channels are expressed and markedly modulated in placenta from preeclamptic women. Differential expression of isoforms may lead to altered cell 2 proliferation. The correlation between KCNQ3 and KCNE5 expression is indicative of a novel channel complex and warrants further investigation.
Introduction
Preeclampsia is a pregnancy-specific condition affecting 2-7% of women and is associated with maternal multi-organ dysfunction 1 . This disorder, which is responsible for approximately 60,000 maternal deaths each year worldwide 2 , increases perinatal mortality five-fold 3 and is commonly associated with preterm delivery and fetal growth restriction 4 . Women who develop preeclampsia and their babies are at increased risk of hypertension, metabolic disorders, cardiovascular disease and cardiovascular death in later life 5, 6 .
The pathophysiology underpinning the disorder is complex. Impaired placentation almost certainly plays a part. Placental and maternal oxidative stress and generalised systemic inflammatory activation 7 are main components of the syndrome 8 . Altered maternal and placental vascular reactivity and endothelial cell function have been implicated in the clinical manifestations of preeclampsia, e.g. an increase in total peripheral vascular resistance (TPVR) 9, 10 , hypertension and altered haemodynamics.
There is emerging evidence to suggest that potassium channels play important roles in the feto-placental vasculature [11] [12] [13] [14] [15] . Specifically, it is proposed that suppression of KV channel function may increase vascular tone and hence be a mechanism affecting perfusion in placentae from women with preeclampsia.
The sub-family of voltage gated KV7 channels (potassium channel complexes encoded by KCNQ1-5 and KCNE1-5 genes) are of particular interest, as preliminary data indicate the 4 presence of functional KV7 channels in human chorionic plate arteries 15 . KV7 channel activity is generally associated with outwardly rectifying, voltage dependent, K + currents 16 . KV7 channels have been identified in numerous blood vessels including human visceral and mesenteric arteries 17 , and the cerebral, carotid, femoral and mesenteric arteries of rodents as well as the aorta and portal vein [18] [19] [20] where they appear to play a role in vascular reactivity. A potential role for these channels in pulmonary hypertension has also been reported 21 . KV7 channels are also important in non-excitable cells such as epithelia [22] [23] [24] and in regulation of cell volume 25 and ion transport (Cl -, Na + ) across epithelia 22, 23 . In skeletal muscle myoblasts, KCNQ5 has been implicated in cellcycle progression and cellular proliferation and differentiation 26 ; but this appears to have been less well studied in vascular smooth muscle. KV channel dysfunction has previously been linked to abnormalities in proliferation and possibly also to remodelling 27 . The presence of KV7 channels in placenta and relative expression in blood vessels, endothelium and syncytiotrophoblast is unknown and the expression profiles in placenta from normotensive and preeclamptic women have not been determined.
The aim of this study, therefore, was to establish KCNQ/KCNE mRNA expression profiles in placentae taken from women with preeclampsia both at term and preterm as well as normotensive controls and confirm regulation and localisation by immunohistochemistry.
Materials and Methods

Human Placental Tissue Collection Subjects
The study population consisted of White European women who had either a normotensive or preeclamptic pregnancy (Table 1) 30 . Doppler velocimetry measurements are not routinely made with preeclampsia in our hospital.
Sample collection
Placental tissue samples were collected from all subjects at a standardised location midway between cord insertion and placental border, avoiding placental infarcts. The placental samples were taken within 10 minutes of delivery; the membranes were removed and tissue washed in ice cold 1 x PBS to remove maternal blood contamination.
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One sample was snap frozen in liquid nitrogen and stored at -80 o C for RNA analysis and another formalin fixed and wax-embedded for immunohistochemical analysis.
RNA extraction and cDNA synthesis
Total RNA (n=22 pre-eclamptics and n=24 normotensive controls) was extracted from a known amount of placental tissue (between 50 to 100 mg) using QIAzol lysis reagent (Qiagen, Crawley, UK). RNA concentration and quality were verified by gel electrophoresis and spectrophotometrically using the Nanodrop ND-1000 (Nanodrop 31 .
Immunohistochemistry
Serial sections of placental tissue were cut (5 μm) in the same orientation from paraffinembedded tissue blocks (Sledge Microtome, Anglia Scientific, Norwich, UK) and mounted onto Superfrost plus glass microscope slides (Menzel-Glaser, Braunschweig, Germany). Before use, sections were dewaxed by immersion in xylene followed by rehydration in descending concentrations of alcohol (3 min each).
Immunohistochemical staining was performed using the Vector Stain Elite ABC kit (Vector Laboratories, US). Two goat polyclonal antibodies (KCNQ3 and KCNE5, SantaCruz Biotechnologies) were employed for immunostaining of paraffin-embedded placental sections (n=6 preeclamptic and n=6 normotensive controls). The optimal dilution for each antibody was established by performing a dilution series, with final selection on the basis of maximal specific reactivity and minimal background staining.
Heat induced epitope retrieval was achieved by heating in a citrate buffer (pH 6.0) using a microwave oven for 15 min followed by incubation for 30 min in normal donkey serum All slides were assessed by the same observer, blinded to pregnancy outcome. For analysis of placental sections, digital images of 5 randomly selected high-power (x400 magnification) fields were captured on NIS-Elements F2.20 microscope (Nikon UK Ltd, Surrey, UK). Quantification of KCNQ3 and KCNE5 were performed as previously described 32 , using the Positive Pixel Algorithm of Aperio ImageScope software. This software is able to discriminate between positive and negative stained pixels, and combines the number of positive pixels stained with the intensity of these same pixels to produce the value 'positivity'. A visual check was also performed to ensure accurate discrimination of immunolabelled regions.
Statistical analysis
We determined that a sample of 22 preeclamptic and 24 normal controls would provide 93% power to detect a difference of 1.25 SD in changes in gene expression with Bonferroni multiple testing. All tests were performed using SPSS for Windows version 16 .0. The Kolmogorov-Smirnov test was used to test for normality of data distribution and summary data are presented as means ± SD or median [interquartile range (IQR)] as appropriate for data distribution. Between-group comparisons were made using 2-tailed Student's t tests/ or Mann-Whitney U-tests depending on the distribution. To assess association between mRNA expression of KCNQ and KCNE forms, data were 9 normalised using log10. Visual inspection suggested a curvilinear association which was tested by regression analysis. The null hypothesis was rejected where P < 0.05. 
Results
Subjects
KCNQ/KCNE expression in placentae from normotensive control versus all preeclamptic women
The expression of KCNQ and KCNE isoforms in placental tissue from normotensive controls (n=24) and women with preeclampsia (n=22), as determined by qRT-PCR is shown in Figure 1 . The relative abundance of placental tissue KCNQs expression in both control and preeclamptic groups was KCNQ3 > KCNQ5> KCNQ2> KCNQ1> KCNQ4.
mRNA for KCNQ3 ( Figure 1A) 
Association of expression of KCNQ3 and KCNE5
The substantial fold increases in both KCNQ3 and KCNE5 mRNA copy number in 
Placental expression of KCNQ/KCNE in normotensive (term), preterm and term preeclampsia
Due to the significant difference between the gestational ages in the control versus preeclamptic cohorts (Table 1) , the preeclamptic group was further subdivided into those who had delivered preterm (<37 weeks; n = 8) and those who delivered at term (n = 14).
Placental KCNQ1 was significantly (p<0.05) up-regulated in preterm labour versus normotensive controls ( Figure 3A ,) while KCNQ5 was significantly suppressed in placenta from preeclamptic women delivering preterm versus normotensive controls ( Figure 3A ; p<0.001). KCNQ4 ( Figure 3A ) and KCNE1 ( Figure 3B ) were significantly down regulated in the preeclamptic group at term versus controls (p<0.05). KCNQ5 was also significantly down-regulated in the preterm, but not term preeclamptic group compared to controls ( Figure 3A ; p<0.001). Interestingly, both KCNQ3 and KCNE5
were significantly increased in preeclamptic placentae delivered at both preterm and term compared to the normotensive controls ( Figure 3A and 3B, p<0.001). There was no significant difference in placental expression of any KCNQ or KCNE isoform when comparing a small subgroup (n= 5) of women with preeclampsia with fetal growth restriction to the remaining preeclamptic women (n=17, p >0.05).
KCNQ3 and KCNE5 encoded protein localisation and expression in control versus preeclamptic placentae
Given the observed differences in mRNA expression for KCNQ3 and KCNE5, we performed immunohistochemistry, to determine protein localization and expression.
Positive expression of both KCNQ3 and KCNE5 was seen in placental tissue from both groups in syncytiotrophoblast cells and in stromal areas, with little expression in the vasculature. Quantification of positive staining revealed that the expression was significantly increased in preeclampsia versus normotensive controls ( Figure 4 ) for both KCNQ3 (p=0.041) and KCNE5 (p=0.015).
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Discussion
This study has established KV7 channel isoform expression profiles in human placental tissue. To our knowledge, this is the first description of altered K + channel expression (involving both α and β subunits) in the placenta of women with preeclampsia. These novel data add to a nascent body of literature concerning K + channels and their role in placental function 14 , and is important given the widespread impact mutations of KV7 channels have on human health (e.g. cardiac arrhythmias, epilepsy, and deafness) 16 . The implications of our data are likely to be multifaceted due to the complex functions of the placenta and the specific KV7 formation channels involved. Altered KV7 channel expression could impact on many areas of placental function including vascular tone, placental proliferation, ion transport or even steroidogenesis.
Our data demonstrates specific up-regulation of KCNQ3 and KCNE5 in placenta from women with preeclampsia and a highly statistically-significant association between them (Figure 2) suggesting the presence of a novel heterodimer (see below). It has been suggested that a majority of KCNQ3 channels exist in a silent state 33 . We speculate that a stimulus associated with pre-eclampsia may lead to activation of these channels, thus enhancing their function. This up-regulation appears most relevant to preeclamptic women as KCNQ3 and KCNE5 remain significantly up-regulated in both term and preterm preeclampsia when compared to normotensive controls. A functional polymorphism (KCNQ3-A315T) has been reported markedly to increase trafficking of KCNQ3 subunits from the endoplasmic reticulum to the cell surface and to increase their stability in neuronal tissue 34 . This polymorphism appears not to have been studied in the 14 placenta or vascular tissue. Other isoforms, KCNQ1, KCNQ4, KCNQ5 and KCNE1 are also differentially modulated in term and preterm preeclampsia. One explanation for these gestation-related differences could be linked to severity of disease in those who deliver at earlier gestations.
The statistically significant association between KCNQ3 and KCNE5 expression in tissues from preeclamptic women (Figure 2 ) could suggest that they may form a novel heterodimeric channel complex. There are no published reports of this channel composition existing in other tissues, but individually, each isoform has been shown to have a range of functions when coupled to other proteins. KCNQ3 along with KCNQ2
and/or KCNQ5 encodes for a channel that underlies the M current, which is important in determining the sub-threshold excitability of neurones 35, 36 . KCNQ3 along with KCNQ5
is highly expressed in bladder smooth muscle 37 . KCNE5 is highly expressed in femoral artery 20 and can modulate KCNQ1 encoded channels with respect to the voltage and time-dependent functions of the channel 38 . Such channel complex specific activity makes it difficult to predict how different KV7 channels may influence placental/vascular function. However, we hypothesise that the observed up-regulation of KCNQ3 and KCNE5 would encode for a KV7 channel subtype that promotes a greater outward potassium current. In this way, alteration in KV7 channel isoforms could be viewed as a compensatory mechanism rather than a primary event responsible for reduced placental perfusion. The observation that KCNQ2/KCNQ3 encoded channels have also recently been shown to be inhibited by angiotensin II may also be relevant as our group and others have reported that there is an increased vascular responsiveness to angiotensin II in preeclampsia [39] [40] [41] . The importance of KV7 channels to vascular reactivity has also been repeatedly demonstrated 18, 20 .
Immunohisotchemistry data also provides some insight into the potential impact of altered KV7 channel composition. The distribution of KCNQ3 and KCNE5 protein was not as localised to vascular regions as might be expected. The greatest protein density was detected in syncytiotrophoblast, which may indicate that placental KV7 channels are related to cell proliferation, angiogenesis or solute transport. Indeed, KV7 channels have been shown to mediate Na + and Cl -transport across other types of epithelia 22, 23 
Perspectives
The marked upregulation of KCNQ3 and KCNE5 KV7 channels in preeclamptic placentae, and their strong association, indicates a potential role for KV7 channels in the aetiology of preeclampsia. This warrants further investigation into the roles KV7 may play in syncytiotrophoblast and other placental cell function such as trophoblast proliferation and migration, as well as, possibly, vascular reactivity. Their modulation and diversity may make them an interesting target for potential therapeutics to treat hypertension.
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